124 related articles for article (PubMed ID: 22052362)
1. Metabolism studies of a small-molecule tumor necrosis factor-alpha (TNF-α) inhibitor, UTL-5b (GBL-5b).
Shaw J; Shay B; Jiang J; Valeriote F; Chen B
Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):83-9. PubMed ID: 22052362
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two molecular scaffolds, 5-methylisoxazole-3-carboxamide and 5-methylisoxazole-4-carboxamide.
Song Y; Zhang Y; Lee AR; Huang WH; Chen B; Palfey B; Shaw J
Curr Pharm Des; 2014; 20(1):146-52. PubMed ID: 23944378
[TBL] [Abstract][Full Text] [Related]
3. A liquid chromatography with tandem mass spectrometry method for simultaneous determination of UTL-5g and its metabolites in human plasma.
Shaw J; Wiegand R; Wu J; Bao X; Valeriote F; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():92-8. PubMed ID: 25955381
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory and Anti-arthritic Effects of a Novel Leflunomide Analogue, UTL-5b (GBL-5b).
Shaw J; Chen B; Wooley P; Huang WH; Lee AR; Zeng D
Am J Biomed Sci; 2011 Jan; 3(1):31-39. PubMed ID: 21253441
[TBL] [Abstract][Full Text] [Related]
5. Using a simple HPLC approach to identify the enzymatic products of UTL-5g, a small molecule TNF-α inhibitor, from porcine esterase and from rabbit esterase.
Swartz K; Zhang Y; Valeriote F; Chen B; Shaw J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():1-6. PubMed ID: 24126042
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolism of leflunomide by mouse and human liver microsomes.
Chan EC; New LS
Drug Metab Lett; 2007 Dec; 1(4):299-305. PubMed ID: 19356059
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism studies on the isoxazole ring scission in the anti-inflammatory agent lefluonomide to its active alpha-cyanoenol metabolite A771726: mechanistic similarities with the cytochrome P450-catalyzed dehydration of aldoximes.
Kalgutkar AS; Nguyen HT; Vaz AD; Doan A; Dalvie DK; McLeod DG; Murray JC
Drug Metab Dispos; 2003 Oct; 31(10):1240-50. PubMed ID: 12975333
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabolism and drug-drug interaction potential of UTL-5g, a novel chemo- and radioprotective agent.
Wu J; Shaw J; Dubaisi S; Valeriote F; Li J
Drug Metab Dispos; 2014 Dec; 42(12):2058-67. PubMed ID: 25249693
[TBL] [Abstract][Full Text] [Related]
9. Chromatographic separation and sensitive determination of teriflunomide, an active metabolite of leflunomide in human plasma by liquid chromatography-tandem mass spectrometry.
Parekh JM; Vaghela RN; Sutariya DK; Sanyal M; Yadav M; Shrivastav PS
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(24):2217-25. PubMed ID: 20643586
[TBL] [Abstract][Full Text] [Related]
10. The small-molecule TNF-alpha modulator, UTL-5g, reduces side effects induced by cisplatin and enhances the therapeutic effect of cisplatin in vivo.
Shaw J; Chen B; Huang WH; Lee AR; Media J; Valeriote FA
J Exp Ther Oncol; 2011; 9(2):129-37. PubMed ID: 21699020
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumour necrosis factor-alpha secretion from EpiDermTM tissues by a novel small molecule, UTL-5d.
Shaw J; Liu C; Martin R; Chen B; Holtz R; Huang WH; Lee AR
Br J Dermatol; 2007 Sep; 157(3):575-9. PubMed ID: 17573867
[TBL] [Abstract][Full Text] [Related]
12. Application of LC/MS/MS in the quantitation of SU101 and SU0020 uptake by 3T3/PDGFr cells.
Zhang Q; Pang WL; Chen H; Cherrington J; Lipson K; Antonian L; Shawver LK
J Pharm Biomed Anal; 2002 May; 28(3-4):701-9. PubMed ID: 12008150
[TBL] [Abstract][Full Text] [Related]
13. Oxidative bioactivation and toxicity of leflunomide in immortalized human hepatocytes and kinetics of the non-enzymatic conversion to its major metabolite, A77 1726.
Seah QM; New LS; Chan EC; Boelsterli UA
Drug Metab Lett; 2008 Aug; 2(3):153-7. PubMed ID: 19356086
[TBL] [Abstract][Full Text] [Related]
14. Characterization of in vitro metabolites of TM-2, a potential antitumor drug, in rat, dog and human liver microsomes using liquid chromatography/tandem mass spectrometry.
Men L; Zhao Y; Lin H; Yang M; Liu H; Tang X; Yu Z
Rapid Commun Mass Spectrom; 2014 Oct; 28(20):2162-70. PubMed ID: 25178720
[TBL] [Abstract][Full Text] [Related]
15. Prediction of biotransformation products of the fungicide fluopyram by electrochemistry coupled online to liquid chromatography-mass spectrometry and comparison with in vitro microsomal assays.
Mekonnen TF; Panne U; Koch M
Anal Bioanal Chem; 2018 Apr; 410(10):2607-2617. PubMed ID: 29455286
[TBL] [Abstract][Full Text] [Related]
16. An integrated approach for profiling oxidative metabolites and glutathione adducts using liquid chromatography coupled with ultraviolet detection and triple quadrupole-linear ion trap mass spectrometry.
Chen G; Cheng Z; Zhang K; Jiang H; Zhu M
J Pharm Biomed Anal; 2016 Sep; 129():482-491. PubMed ID: 27497649
[TBL] [Abstract][Full Text] [Related]
17. The small-molecule TNF-α inhibitor, UTL-5g, delays deaths and increases survival rates for mice treated with high doses of cisplatin.
Shaw J; Media J; Chen B; Valeriote F
Cancer Chemother Pharmacol; 2013 Sep; 72(3):703-7. PubMed ID: 23881213
[TBL] [Abstract][Full Text] [Related]
18. Structural elucidation of in vitro metabolites of emodin by liquid chromatography-tandem mass spectrometry.
Song R; Xu F; Zhang Z; Liu Y; Dong H; Tian Y
Biomed Chromatogr; 2008 Nov; 22(11):1230-6. PubMed ID: 18651591
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical metabolite profiling using quadrupole/ion mobility spectrometry/time-of-flight mass spectrometry.
Chan EC; New LS; Yap CW; Goh LT
Rapid Commun Mass Spectrom; 2009 Feb; 23(3):384-94. PubMed ID: 19127546
[TBL] [Abstract][Full Text] [Related]
20. Application of a fluorous derivatization method for characterization of glutathione-trapped reactive metabolites with liquid chromatography-tandem mass spectrometry analysis.
Nishijo N; Hayama T; Tomita R; Yamaguchi M; Fujioka T
J Chromatogr A; 2020 Jul; 1622():461160. PubMed ID: 32450990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
